×
About 423 results

ALLMedicine™ Eosinophilic Gastroenteritis Center

Research & Reviews  139 results

Abdominal Pain Due to Eosinophilic Gastroenteritis Diagnosed in 25-Year-Old and 27-Year...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037115
The American Journal of Case Reports; Mulya DP, Adiwena N et. al.

Mar 20th, 2023 - BACKGROUND Eosinophilic gastroenteritis (EG) can be associated with parasitic infections, atopic drug reactions, or atopic diseases, such as asthma. This report describes 25-year-old and 27-year-old sisters with a family history of asthma who pres...

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
https://clinicaltrials.gov/ct2/show/NCT05214768

Feb 24th, 2023 - The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.

Primary Eosinophilic Colitis in Symptomatic Patients.
https://clinicaltrials.gov/ct2/show/NCT05719727

Feb 10th, 2023 - The presence of eosinophils in the different segments of the digestive tract is common and seen in diverse clinical scenarios. Eosinophilic gastrointestinal diseases (EGIDs) are a group of disorders characterized by symptoms of gastrointestinal dy...

Serum Ascites Albumin Gradient (SAAG) Interpretation
http://emedicine.medscape.com/article/2172621-overview

Jan 20th, 2023 - SAAG Interpretation The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin...

Serum Ascites Albumin Gradient (SAAG) Interpretation
https://emedicine.medscape.com/article/2172621-print

Jan 20th, 2023 - The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin A high gradient (SA...

see more →

Clinicaltrials.gov  17 results

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
https://clinicaltrials.gov/ct2/show/NCT05214768

Feb 24th, 2023 - The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.

Primary Eosinophilic Colitis in Symptomatic Patients.
https://clinicaltrials.gov/ct2/show/NCT05719727

Feb 10th, 2023 - The presence of eosinophils in the different segments of the digestive tract is common and seen in diverse clinical scenarios. Eosinophilic gastrointestinal diseases (EGIDs) are a group of disorders characterized by symptoms of gastrointestinal dy...

Eosinophilic Gastrointestinal Disorders Registry
https://clinicaltrials.gov/ct2/show/NCT05199532

Feb 7th, 2022 - Eosinophilic gastrointestinal disorders (EGIDs) comprise a family of disorders that includes Eosinophilic Esophagitis (EoE), Eosinophilic Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosinophilic Colitis (EC). The natural history of EGI...

Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
https://clinicaltrials.gov/ct2/show/NCT02897271

Sep 28th, 2021 - This retrospective chart review study will analyze the demographics, medical history, clinical features, and pathological data of patients with Eosinophilic Gastrointestinal Disorders (EGIDs) other than Eosinophilic Esophagitis (EoE) alone, includ...

A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
https://clinicaltrials.gov/ct2/show/NCT04322604

Aug 3rd, 2021 - This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002), given monthly for 6 doses, in patients with moderately to severely active Eosinophilic Gastritis and/or ...

see more →

News  12 results

Experts refine nomenclature for eosinophilic GI disorders
https://www.mdedge.com/gihepnews/article/258532/upper-gi-tract/experts-refine-nomenclature-eosinophilic-gi-disorders
Jim Kling, MDedge News

Oct 10th, 2022 - A new international consensus paper is recommending that eosinophilic GI diseases (EGIDs) should be named according to more specific criteria. The paper seeks to update nomenclature to improve research and bolster clinical clarity.

Experts refine nomenclature for eosinophilic GI diseases
https://www.mdedge.com/gihepnews/article/258532/upper-gi-tract/experts-refine-nomenclature-eosinophilic-gi-diseases
Jim Kling, MDedge News

Oct 10th, 2022 - A new international consensus paper is recommending that eosinophilic GI diseases (EGIDs) should be named according to more specific criteria. The paper seeks to update nomenclature to improve research and bolster clinical clarity.

Updates in eosinophilic gastrointestinal diseases
https://www.mdedge.com/gihepnews/article/258193/upper-gi-tract/updates-eosinophilic-gastrointestinal-diseases
Kathryn A. Peterson, MD, MSCI

Sep 23rd, 2022 - Eosinophilic gastrointestinal diseases (EGIDs) are characterized by GI signs or symptoms occurring along with tissue eosinophilia. Eosinophilic esophagitis (EoE) is the more commonly recognized EGID as endoscopic and histopathologic diagnostic cri.

Eosinophilic diseases often overlap, raising costs
https://www.mdedge.com/internalmedicine/article/255002/gastroenterology/eosinophilic-diseases-often-overlap-raising-costs
Jim Kling

May 26th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U. S.

IBD or something else? Key characteristics offer clues
https://www.mdedge.com/internalmedicine/article/251943/gastroenterology/ibd-or-something-else-key-characteristics-offer
Nancy A. Melville

Feb 18th, 2022 - Immune-mediated inflammatory diseases (IMIDs) of the gastrointestinal (GI) tract, with features that often mimic each other, commonly present clinical challenges. But key characteristics can help distinguish the most common – inflammatory bowel di.

see more →

Patient Education  1 results see all →